September 26, 2025 | Pharma Tariffs, IT Pressure, and Risk-Off Signals

Good Morning & Market Recap

• Domestic markets extended losses for a fifth straight session. The Nifty 50 closed lower, the Sensex declined, and Bank Nifty also finished in the red. Persistent foreign portfolio outflows and the newly announced US H-1B visa fee continue to weigh heavily on IT sentiment.
• Overnight in the US, markets registered a third consecutive loss as stronger economic data tempered expectations of rapid Federal Reserve rate cuts. Inflation data due later tonight remains the next key global cue.
• What’s different today: GIFT Nifty signals a soft-to-flat opening even as crude prices push higher following Russia’s fuel export curbs. The rupee remains near record-weak levels, adding to macro pressure.

Overnight developments intensified concerns after President Trump announced steep tariffs on branded pharmaceutical products effective October 1. The Nifty has now slipped below the psychological 25,000 mark after five consecutive sessions of decline. Key watch factors include the sectoral impact of pharma tariffs and sustained foreign selling pressure.

Tech Pulse

Global tech sentiment weakened as Asian markets opened lower following tariff announcements. The proposed pharmaceutical tariffs target branded and patented products unless companies are actively building manufacturing facilities in the US. Indian pharma stocks face added pressure given India’s significant share in supplying generic and biosimilar drugs to the US market.

Actionable trigger: Monitor opening reactions in pharma stocks and any company-specific disclosures around US manufacturing plans.

Funding Radar

India’s startup ecosystem has raised $7.7 billion in the first nine months of 2025, positioning the country as the third-most funded market globally. While funding remains lower than last year, resilience is visible across electronics manufacturing, renewable energy, fintech, and emerging technology sectors.

Recent activity highlights continued institutional interest in industrial transition themes, with capital flowing into electronics, clean energy, logistics, and consumer platforms that demonstrate cost efficiency and scalability.

Market Movers & Watchlist

Pharmaceutical majors remain under immediate pressure due to tariff headwinds, while banking stocks struggle near key support zones amid continued foreign selling. Currency weakness remains a concern, with the rupee hovering near record lows.

• Energy complex remains in focus as higher crude prices impact refining and marketing margins.
• IT sentiment stays fragile following visa-fee developments, with large-cap commentary closely watched.
• Banks show mixed performance, with selective resilience in PSU names but limited follow-through ahead of month-end flows.

Actionable watch:
Focus on crude-linked stocks for margin signals, IT majors for guidance on cost pass-through, and banking breadth near key technical levels.

Quick Bytes (Global / Off-Radar)

Japan’s inflation remains above target, keeping expectations of policy tightening alive. US growth data was revised higher, driven by strong investment in data centers and GPU infrastructure. Defense stocks are rallying globally amid increased military spending.

Deep Dive – Trump’s Pharma Gambit

The proposed pharmaceutical tariffs aim to accelerate onshoring of drug manufacturing in the US, targeting a large volume of imported generics and branded medicines. For Indian pharma companies, this represents a strategic inflection point: either absorb margin pressure or accelerate US manufacturing investments.

Peer comparisons suggest similar pressures for European pharma firms under existing trade frameworks.

Investor takeaway: Track company-specific announcements on US facilities and evaluate which Indian players already possess domestic manufacturing capabilities.

What to Watch Today

• US personal income and spending data, along with sentiment indicators
• Currency movement and RBI commentary on rupee volatility
• Asian market performance and US futures reaction to tariff news

Quote of the Day

“India’s climb to the third rank globally underscores the resilience and adaptability of its startup ecosystem.”
— Neha Singh, Co-Founder, Tracxn

Compliance & Disclaimer

This newsletter is for informational purposes only and does not constitute investment advice. Market data is sourced from multiple verified platforms and cross-validated per editorial standards. Investors should conduct independent research and consult qualified advisors before making investment decisions. Past performance does not guarantee future results.

‍